AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells. (2019)
Attributed to:
Manchester Academic Health Science Centre Technology Hub: Clinical Proteomics Centre for Stratified Medicine
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1097/hs9.0000000000000233
PubMed Identifier: 31723838
Publication URI: http://europepmc.org/abstract/MED/31723838
Type: Journal Article/Review
Volume: 3
Parent Publication: HemaSphere
Issue: 3
ISSN: 2572-9241